Aspira Womens Income Before Tax Over Time
| AWH Stock | USD 0.73 0.02 2.67% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Aspira Womens Performance and Aspira Womens Correlation. Aspira |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.801 | Quarterly Revenue Growth (0.03) | Return On Assets (1.86) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Income Before Tax Analysis
Compare Aspira Womens Health and related stocks such as BioAffinity Technologies, Amer Bio Medica, and Arrayit Income Before Tax Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIAFW | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (7.3 M) | (6.3 M) | (8.2 M) | (7.9 M) | (8.3 M) |
| ARYC | (248.6 K) | (248.6 K) | (576.5 K) | (381.9 K) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3 M) | (2.8 M) |
| RDNT | (58.3 M) | 2.9 M | (2.1 M) | 5.9 M | 3.7 M | 14.6 M | 12.4 M | 26.4 M | 38.5 M | 29.7 M | (854 K) | 58.9 M | 43 M | 38.8 M | 40.8 M |
| BDSX | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (26.2 M) | (30.7 M) | (31.4 M) | (43.2 M) | (65.4 M) | (52.1 M) | (54.8 M) |
| BNR | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (131.3 M) | (177.5 M) | (169.2 M) | (407.2 M) | (795.8 M) | (969.2 M) | (651.3 M) | (683.9 M) |
| STIM | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (16.1 M) | (24.1 M) | (29 M) | (27.5 M) | (31.2 M) | (37.2 M) | (30.2 M) | (31.7 M) |
| DRIO | (5.7 M) | (5.7 M) | (5.7 M) | (13.9 M) | (12.9 M) | (7.1 M) | (10.9 M) | (15.7 M) | (17.8 M) | (17.7 M) | (29.4 M) | (76.7 M) | (62.2 M) | (59.4 M) | (56.4 M) |
| SERA | (16.5 M) | (16.5 M) | (16.5 M) | (16.5 M) | (16.5 M) | (16.5 M) | (16.5 M) | (16.5 M) | (16.5 M) | (16.5 M) | (19.8 M) | (35 M) | (44.2 M) | (36.2 M) | (38.1 M) |
| FONR | (6.3 M) | 7 M | 8 M | 11 M | 12.8 M | 14.5 M | 19.3 M | 19.8 M | 22.5 M | 14.1 M | 17.7 M | 22.8 M | 15.8 M | 19.3 M | 20.2 M |
| XGN | (7.3 M) | (7.3 M) | (7.3 M) | (13.5 M) | (15 M) | (18.9 M) | (26.2 M) | (26.2 M) | (8 M) | (12 M) | (16.8 M) | (26.7 M) | (47.7 M) | (23.7 M) | (24.8 M) |
Aspira Womens Health and related stocks such as BioAffinity Technologies, Amer Bio Medica, and Arrayit Income Before Tax description
Income Before Tax which can also be referred as pre-tax income is reported on Aspira Womens income statement and is an important metric when analyzing Aspira Womens Health profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.My Equities
My Current Equities and Potential Positions
| Aspira Womens Health | AWH |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Texas; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.73
Check out Aspira Womens Performance and Aspira Womens Correlation. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Aspira Womens technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.